[1]石亚丽,张 颖,王 书.衰弱与老年慢性心力衰竭的相关性分析[J].医学信息,2021,34(05):81-84.[doi:10.3969/j.issn.1006-1959.2021.05.023]
　SHI Ya-li,ZHANG Ying,WANG Shu.Correlation Analysis Between Frailty and Chronic Heart Failure in the Elderly[J].Medical Information,2021,34(05):81-84.[doi:10.3969/j.issn.1006-1959.2021.05.023]
点击复制

衰弱与老年慢性心力衰竭的相关性分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年05期
页码:
81-84
栏目:
论著
出版日期:
2021-03-01

文章信息/Info

Title:
Correlation Analysis Between Frailty and Chronic Heart Failure in the Elderly
文章编号:
1006-1959（2021）05-0081-04
作者:
石亚丽; 张 颖; 王 书
（安徽医科大学第三附属医院/合肥市第一人民医院老年病科干部病房，安徽 合肥 230061）
Author(s):
SHI Ya-li; ZHANG Ying; WANG Shu
(Department of Geriatrics,the Third Affiliated Hospital of Anhui Medical University/Cadre Ward,Hefei First People’s Hospital, Hefei 230061,Anhui,China)
关键词:
衰弱; 心力衰竭; 心功能分级
Keywords:
Frailty; Heart failure; Heart function classification
分类号:
R541.6
DOI:
10.3969/j.issn.1006-1959.2021.05.023
文献标志码:
A
摘要:
目的 分析衰弱与老年慢性心力衰竭的相关性。方法 收集2019年9月~2020年3月我院收治的236例老年心衰患者临床资料，根据Fried衰弱评估标准分为衰弱组和非衰弱组，比较两组一般资料、实验室资料、心超资料，并采用多因素Logistic回归分析老年住院心衰患者合并衰弱的危险因素。结果 236例老年心衰患者中存在衰弱者136例，占比57.63%。衰弱组与非衰弱组年龄、心功能分级、合并有肾功能不全、有扩心病、血红蛋白、血尿酸、肌酐、BNP、CRP、LVEF、主动脉内径、左室舒张末内径、左室收缩末内径、室间隔厚度，左室后壁厚度比较，差异有统计学意义（P＜0.05）；多因素Logistic回归分析显示，心功能分级、肌酐、LVEF、主动脉内径为老年住院心衰患者合并衰弱的危险因素。结论 住院老年心衰患者衰弱患病率较高，且心功能分级、肌酐、LVEF、主动脉内径与发生心衰合并衰弱密切相关，临床可据以上危险因素制作心衰患者有效的衰弱预测模型，形成有效的衰弱评估方法。
Abstract:
Objective To analyze the correlation between frailty and chronic heart failure in the elderly.Methods The clinical data of 236 elderly patients with heart failure admitted to our hospital from September 2019 to March 2020 were collected and divided into debilitating group and non-debilitating group according to Fried frailty assessment criteria.The general data, laboratory data, and echocardiographic data of the two groups were compared, and multivariate Logistic regression was used to analyze the risk factors of elderly inpatients with heart failure and weakness.Results Among 236 elderly patients with heart failure, 136 were debilitated, accounting for 57.63%.Age, cardiac function classification, combined with renal insufficiency, diarrhea, hemoglobin, blood uric acid, creatinine, BNP, CRP, LVEF, aortic inner diameter, left ventricular end diastolic inner diameter, left ventricular end systolic inner diameter,the thickness of the ventricular septum, the thickness of the posterior wall of the left ventricle,the difference was statistically significant (P＜0.05);Multivariate Logistic regression analysis showed that cardiac function classification, creatinine, LVEF, and aortic diameter were risk factors for elderly hospitalized heart failure patients with weakness.Conclusion The prevalence of frailty in hospitalized elderly patients with heart failure is relatively high, and the classification of heart function, creatinine, LVEF, and aortic diameter are closely related to the occurrence of heart failure with frailty.Clinically, an effective frailty prediction model for patients with heart failure can be made based on the above risk factors to form an effective frailty assessment method.

参考文献/References:

[1]王荣英,贺振银,赵稳稳,等.慢性病管理研究进展[J].中国全科医学,2016,19(17):1989-1993. [2]Vitale C,Uchmanowicz I.Frailty in patients with heart failure[J].Eur Heart J Suppl,2019,21(Suppl L):L12-L16. [3]杨凯,金明磊.某三级医院住院老年心衰患者衰弱状况及影响因素分析[J].承德医学院学报,2019,36(1):34-37. [4]Denfeld QE,Winters-Stone K,Mudd JO,et al.The prevalence of frailty in heart failure：a systematic review and meta-analysis[J].Int J Cardiol,2017,236(2):283-289. [5]郝秋奎,李峻,董碧蓉,等.老年患者衰弱评估与干预中国专家共识[J].中华老年医学杂志,2017,36(3):251-256. [6]Newman AB,Gottdiener JS,Ann MBM,et al.Associations of subclinical cardiovascular disease with frailty[J].Journals of Gerontology,2001(3):M158-M166. [7]刘慧珍,马丽娜.衰弱对老年人心血管病影响的研究进展[J].疑难病杂志,2017,16(8):844-847. [8]Pandey A,Kitzman D,Reeves G.Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management[J].JACC Heart Fail,2019,7(12):1001-1011. [9]Sze S,Pellicori P,Zhang J,et al.Identification of Frailty in Chronic Heart Failure[J].JACC Heart Fail,2019,7(4):291-302. [10]江恒,夏丽莉,刘滢.老年慢性心力衰竭病人衰弱相关因素分析[J].实用老年医学,2020,34(6):83-86. [11]赵雪梅.肝肾功能对住院心力衰竭患者的风险评估[D].北京协和医学院,2016. [12]Fried LP,Kronmal RA,Newman AB,et al.Risk factors for 5-year mortality in older adults:the Cardiovascular Health Study[J].JAMA,1998,279(8):585-592. [13]Uchmanowicz I,Nessler J,Gobbens R,et al.Coexisting Frailty With Heart Failure[J].Frontiers In Physiology,2019(10):791. [14]Khan H,Kalogeropoulos AP,Georgiopoulou VV,et al.Frailty and risk for heart failure in older adults:The health, aging,and body composition study[J].American Heart Journal,2013,166(5):887-894. [15]Jha SR,Ha HSK,Hickman LD,et al.Frailty in advanced heart failure:a systematic review[J].Heart Failure Reviews,2015,20(5):553-560.

相似文献/References:

[1]郭俊林,张立.BNP对CRT后期疗效的临床评价[J].医学信息,2018,31(01):67.[doi:10.3969/j.issn.1006-1959.2018.01.024]
　GUO Jun-lin,ZHANG li.Clinical Evaluation of BNP in Treatment of Late CRT[J].Medical Information,2018,31(05):67.[doi:10.3969/j.issn.1006-1959.2018.01.024]
[2]程 林.重组人脑利钠肽用于重症急性心肌炎伴 心力衰竭患者治疗的临床研究[J].医学信息,2018,31(08):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
　CHENG Lin.Clinical Study of Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Severe Acute Myocarditis and Heart Failure[J].Medical Information,2018,31(05):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
[3]胡丽君.螺内酯联合曲美他嗪治疗慢性心力衰竭的疗效分析[J].医学信息,2018,31(08):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
　HU Li-jun.Efficacy of Spironolactone Combined with Trimetazidine in the Treatment of Chronic Heart Failure[J].Medical Information,2018,31(05):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
[4]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Medical Information,2018,31(05):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[5]姜小红,严琴琴,周连锁,等.老年衰弱的干预措施现状研究[J].医学信息,2022,35(09):76.[doi:10.3969/j.issn.1006-1959.2022.09.019]
　JIANG Xiao-hong,YAN Qin-qin,ZHOU Lian-suo,et al.Study on the Current Situation of Intervention Measures for Elderly Frailty[J].Medical Information,2022,35(05):76.[doi:10.3969/j.issn.1006-1959.2022.09.019]
[6]孔玉涛.虚拟现实技术改善老年人衰弱状态的研究现状[J].医学信息,2022,35(09):54.[doi:10.3969/j.issn.1006-1959.2022.09.013]
　KONG Yu-tao.Research Status of Virtual Reality Technology in Improving Aged Frailty[J].Medical Information,2022,35(05):54.[doi:10.3969/j.issn.1006-1959.2022.09.013]
[7]平兰芝,黄小楼,胡天俊,等.CaMKⅡ在心血管疾病中的研究[J].医学信息,2022,35(10):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
　PING Lan-zhi,HUANG Xiao-lou,HU Tian-jun,et al.Research on the Role of CaMKⅡ in Cardiovascular Diseases[J].Medical Information,2022,35(05):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
[8]刘革铭,马洪俊,刘 毅,等.心力衰竭的机制及诊疗的研究[J].医学信息,2022,35(10):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
　LIU Ge-ming,MA Hong-jun,LIU Yi,et al.Mechanism, Diagnosis and Treatment of Heart Failure[J].Medical Information,2022,35(05):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
[9]黄光明,赵兴昌,符显昭.水中运动联合中药内治对糖尿病大鼠心肌细胞凋亡和心功能的影响[J].医学信息,2022,35(11):72.[doi:10.3969/j.issn.1006-1959.2022.11.020]
　HUANG Guang-ming,ZHAO Xing-chang,FU Xian-zhao.Effects of Aquatic Therapeutic Exercise Combined with Traditional Chinese Medicine Internal Treatment on Cardiomyocyte Apoptosis and Cardiac Function in Diabetic Rats[J].Medical Information,2022,35(05):72.[doi:10.3969/j.issn.1006-1959.2022.11.020]
[10]何玲玲,程淑芬.曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭疗效观察[J].医学信息,2018,31(13):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
　HE Ling-ling,CHENG Shu-fen.Therapeutic Effect of Trimetazidine Combined with Metoprolol Succinate in the Treatment of Coronary Heart Disease with Heart Failure[J].Medical Information,2018,31(05):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]

更新日期/Last Update: 1900-01-01